Wu Huaxiang

[Expert Profile] Wu Huaxiang, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in rheumatology and immunology in China, working in the Department of Rheumatology, The Second Affiliated Hospital, Zhejiang University School of Medicine. She has long been dedicated to the clinical diagnosis, treatment, and scientific research of ankylosing spondylitis, spondyloarthropathy, and difficult rheumatic diseases, and is a leading figure in rheumatology in Zhejiang Province.

[Education & Career] Professor Wu Huaxiang graduated from Zhejiang Medical University, completed systematic clinical training at the Second Affiliated Hospital of Zhejiang University School of Medicine, and further studied at famous international rheumatology centers. She has long served as Director of the Rheumatology Department at the Second Affiliated Hospital, holding academic positions including standing committee member of the Rheumatology Branch of the Chinese Medical Association and Chair of the Rheumatology Branch of the Zhejiang Medical Association. She has presided over grants from the National Natural Science Foundation of China and major provincial and ministerial projects, and is an important discipline leader in rheumatology in Zhejiang.

[Areas of Expertise] Professor Wu specializes in the diagnosis and treatment of spondyloarthritis spectrum diseases including ankylosing spondylitis, psoriatic arthritis, and reactive arthritis, as well as comprehensive management of various rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus. She has extensive experience in early diagnosis, imaging assessment, and standardized application of biologics (such as TNF inhibitors, IL-17 inhibitors) for spondyloarthritis. She excels at managing difficult cases of "chronic back pain with prominent morning stiffness," helping numerous spondyloarthritis patients control inflammation, delay joint deformity, and restore normal mobility.

[Academic Achievements & Industry Contributions] Professor Wu has led a series of clinical studies on spondyloarthritis such as ankylosing spondylitis, systematically evaluating the efficacy and safety of biologics in Chinese patients, with findings published in authoritative domestic and international journals. She has participated in the development of Chinese ankylosing spondylitis and rheumatology diagnosis and treatment guidelines, actively promoted the popularization of standardized spondyloarthritis diagnosis and treatment in Zhejiang, and led the construction of regional rheumatology specialist alliances, organizing difficult case consultations and grassroots training, significantly improving the overall diagnosis and treatment level of rheumatology in the region.

[Clinical Practice & Outstanding Contributions] Professor Wu has long held expert rheumatology clinics, cumulatively treating tens of thousands of patients with ankylosing spondylitis and various rheumatic diseases, relieving suffering and restoring upright posture for countless patients who "could not straighten their backs." She is friendly and responsible with patients, values doctor-patient communication and whole-course management, and is deeply trusted by patients. She has repeatedly organized rheumatology science popularization and free clinics, actively advocating "early diagnosis, early treatment, and standardized follow-up," and is a widely respected expert in the field of rheumatology not only in Zhejiang but nationwide.

[Honors & Reputation] Professor Wu Huaxiang serves as Chair of the Rheumatology Branch of the Zhejiang Medical Association, among other academic positions. She has presided over grants from the National Natural Science Foundation of China and major provincial and ministerial projects, and is an important discipline leader in rheumatology in Zhejiang Province. She has accumulated extensive experience in the diagnosis and treatment of difficult cases of ankylosing spondylitis and spondyloarthropathy. She has led the establishment of a standardized spondyloarthritis diagnosis and treatment and follow-up system, promoted individualized biologic application and early intervention concepts, participated in the development of multiple rheumatology diagnosis and treatment guidelines, and has research findings published in authoritative domestic and international journals. For decades on the clinical front lines and grassroots support, she has helped numerous ankylosing spondylitis patients control their conditions and avoid deformity, and is deeply trusted by patients and respected by peers alike.